Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is a once-weekly injection, not a daily tablet, so the before-or-after-eating question works differently than it does for most medicines. The licensed dosing schedule carries no requirement to inject before or after food — timing relative to meals does not affect how well semaglutide is absorbed from a subcutaneous injection. What the NHS semaglutide guidance does specify is a consistent weekly day, the correct injection technique, and rotating sites — not a meal window. That said, many people find that understanding when nausea tends to peak, and how food choices interact with that, makes the first weeks of treatment noticeably more comfortable. These are prescription-only medicines; a GPhC-registered prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (68 weeks, 1,961 adults with obesity, published in the New England Journal of Medicine) established semaglutide 2.4mg as effective for weight management without any specified meal-timing protocol for the injection. Participants injected once weekly on a chosen consistent day; the protocol was silent on food proximity because it is irrelevant to subcutaneous absorption. Unlike oral medicines that pass through the gut and can be affected by gastric contents, a subcutaneous injection delivers the medicine directly into fatty tissue, bypassing the digestive process entirely. The medicine enters circulation from there regardless of what is in your stomach.
This matters because a great deal of online discussion about "before or after food" applies to oral GLP-1 medicines, not injections. If you are reading about semaglutide and food timing for injection, you can set the pharmacokinetics question aside. The practical question that does remain relevant is simpler: on the day you inject, how can you eat in a way that keeps you comfortable?
Semaglutide slows gastric emptying, which is part of how it reduces appetite. That slower transit also means a large, rich or very fatty meal sits in the stomach longer, and for some people that amplifies nausea, particularly during the early weeks or after a dose step-up. The interaction is about comfort, not absorption.
The NHS notes that nausea and vomiting are among the most common side effects of semaglutide, typically most noticeable when starting or after a dose increase, and usually settling over days to a couple of weeks. There is no single rule that works for every person, but a few practical patterns appear consistently in clinical experience.
Injecting on a day when you know you can eat lightly and without time pressure tends to be easier than injection-day travel or a large celebration meal. Smaller portions, lower-fat food choices and eating slowly all reduce the gastric load that slower emptying has to work through. Trying to eat less than usual is usually not the goal (your appetite will likely already be lower) but what you choose to eat on Wegovy can genuinely affect how settled your stomach feels in those first weeks.
A quick checking habit worth building: before you inject each week, glance at what you have planned to eat that day. If you know a heavy meal is coming (a birthday, a work lunch) some people prefer to shift their injection day by 24 hours, which the PIL typically permits if the gap between doses remains adequate. Check with your prescriber before building that into a routine.
Cold or room-temperature foods tend to sit better than very hot ones for some people early in treatment. Fizzy drinks and alcohol can add to bloating when gastric emptying is slower. None of this is a protocol, it is pattern recognition from clinical practice, and most people find their relationship with food settles as their body adjusts.
For most people, gastrointestinal side effects are front-loaded: worst in weeks one to four, better by weeks six to eight, manageable by the time the dose increases again. If nausea is severe, persistent or accompanied by vomiting that prevents eating normally, that is not a food-timing problem to solve independently. The NHS guidance on semaglutide lists the signs that need prompt medical attention: severe stomach pain (especially pain that radiates to the back) which can indicate pancreatitis, a rare but serious condition flagged in an MHRA Drug Safety Update for GLP-1 medicines.
Dehydration from persistent vomiting is also a clinical concern, not a reason to try a different injection time relative to meals. If side effects are significantly affecting daily life, speak to your prescriber. At nume, aftercare is available seven days a week for exactly these conversations, you are not left to manage adjustments alone. A prescriber can review whether a slower titration pace or other support is appropriate.
The question of eating after taking Wegovy sometimes reflects anxiety about "cancelling out" the injection, that is not how the medicine works. Eating normally is expected and encouraged; the injection functions regardless. Similarly, questions about eating before Wegovy often stem from the same uncertainty. The short answer in both cases is that neither timing affects efficacy.
It is worth being clear about one distinction that genuinely matters. The Wegovy tablet (oral semaglutide, approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) has very specific food-timing requirements. It must be taken first thing in the morning on an empty stomach, with a small amount of plain water, and you wait at least 30 minutes before any food, drink or other medicines. That restriction exists because the absorption enhancer in the tablet is highly sensitive to gastric contents, entirely unlike a subcutaneous injection.
If you are reading about Wegovy timing in the context of the tablet, the rules are strict and different from the injection. Your prescriber and the Patient Information Leaflet give the definitive instructions for whichever formulation you are using.
For the weekly injection, though, the answer remains: pick a consistent day, inject correctly, rotate your sites, and focus your food choices on what keeps you comfortable, not on a pharmacological meal window that does not exist. If you are weighing up your options for medically supervised weight management, our prescribers can talk through which approach fits your routine.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.